Premenstrual syndrome treatment market size was valued at US$ 1,501 million in 2024 and is projected to hit the market valuation of US$ 2,155 million by 2033 at a CAGR of 4.1% during the forecast period 2025–2033.
Artificial insemination market was valued at US$ 2.8 billion in 2024 and is projected to hit the market valuation of US$ 5.5 billion by 2033 at a CAGR of 7.9% during the forecast period 2025–2033.
Nanocellulose market size was pegged at US$ 709.7 million in 2024 and is projected to hit the market valuation of US$ 4,213.9 million by 2033 at a CAGR of 21.9% during the forecast period 2025–2033.
Stem cell manufacturing market was valued at US$24.26 billion in 2024 and is projected to hit the market valuation of US$ 65.49 billion by 2033 at a CAGR of 11.96% during the forecast period 2025–2033.
Penicillin G acylase market was valued at US$ 151.3 million in 2024 and is projected to hit the market valuation of US$ 251.4 million by 2033 at a CAGR of 5.8% during the forecast period 2025–2033.
Intravenous hydration therapy market was valued at US$ 2.8 billion in 2024 and is projected to hit the market valuation of US$ 4.9 billion by 2033 at a CAGR of 6.2% during the forecast period 2025–2033.
US cell culture supplements market was valued at US$ 835.9 million in 2024 and is projected to hit the market valuation of US$ 2,491.6 million by 2033 at a CAGR of 12.9% during the forecast period 2025–2033.
